The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | N | Nervous system | |
| 2 | N06 | Psychoanaleptics | |
| 3 | N06A | Antidepressants | |
| 4 | N06AX | Other antidepressants | |
| 5 | N06AX24 | Vilazodone |
| Active Ingredient | Description | |
|---|---|---|
| Vilazodone |
Vilazodone is a selective serotonin reuptake inhibitor and a 5HT1A receptor partial agonist. It is used for the treatment of major depressive disorder (MDD) in adults. The mechanism of action of vilazodone in the treatment of major depressive disorder is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS through selective inhibition of serotonin reuptake. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| VIIBRYD Tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
